Načítá se...
Applying a Risk-benefit Analysis to Outcomes in Tuberculosis Clinical Trials
Although it is common to analyze efficacy and safety separately in clinical trials, this could yield a misleading study conclusion if an increase in efficacy is accompanied by a decrease in safety. A risk-benefit analysis is a systematic approach to examine safety and efficacy jointly. Both the “ran...
Uloženo v:
| Vydáno v: | Clin Infect Dis |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7319261/ https://ncbi.nlm.nih.gov/pubmed/31414121 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciz784 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|